CT grant program seeking health tech entrepreneurs; Bioasis CEO exits
25 Apr 2019
The Connecticut Bioscience Pipeline, a state-backed program that aims to help entrepreneurs turn medical technology ideas into new business ventures, announced it is accepting applications for its latest funding round.
The state's quasi-public venture capital arm, Connecticut Innovations, said it will accept applications through 5 p.m. on April 26.
Launched in 2015, the pipeline is a partnership between CI, Yale University, Quinnipiac University and the University of Connecticut. It allows entrepreneurs and early-stage companies in the medical devices, drug delivery, diagnostics or health IT spaces to compete for grants.
Through the program, teams can qualify for up to $30,000 over 12 months to be used for business strategy, market definition and prototyping and proof-of-concept activities, program officials said.
Eligible applicants may include established companies, student groups or faculty members, all of whom must be affiliated with a Connecticut university. Projects from the pharmaceuticals, biopharmaceuticals and fundamental biology sectors are ineligible.